Future Market Insights.png
Global Breast Reconstruction Surgery Market Set for Exponential Growth, Projected to Surpass USD 10,117.8 Million by 2035 witness at a CAGR of 7.5% | Future Market Insights, Inc.
February 07, 2025 06:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global breast reconstruction surgery market is set for remarkable expansion, with market projections indicating a 7.5% CAGR from 2025 to 2035....
Logo_UCBC.jpg
University Cancer & Blood Center’s Dr. Ashley Ray receives oncoplastic breast surgery certification
February 06, 2025 11:48 ET | University, Cancer and Blood Center
University Cancer & Blood Center (UCBC), based in Athens, Georgia, announces that Dr. Ashley Ray now has her certification in oncoplastic breast surgery.
myriad_S_stacked.png
Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
February 06, 2025 08:30 ET | Myriad Genetics, Inc.
Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.
Music of Your Life Gears Up for Milestone 50th Anniversary Celebration
February 05, 2025 08:00 ET | The Marquie Group, Inc.
Music of Your Life Gears Up for Milestone 50th Anniversary Celebration
Atossa_Therapeutics_logo-min.png
Atossa Therapeutics Congratulates Board Director Dr. Tessa Cigler and Weill Cornell Medicine on CDC Grant to Enhance Breast Cancer Care
February 05, 2025 08:00 ET | Atossa Therapeutics, Inc.
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment...
Straits Logo 1-01 (1).png
Cancer Diagnostics Market Size is Expected to Reach USD 178.26 Billion by 2033, Growing at a CAGR of 5.91%: Straits Research
February 03, 2025 08:25 ET | Straits Research Private Limited - Garner Insights
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cancer diagnostics is the process of identifying biomarkers, proteins, and other indicators that assist in identifying a cancerous tumor....
arvinas_logoART_lg.jpg
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
February 03, 2025 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Announces Clinical Breast Cancer Publication of Article Examining Effects of Lasofoxifene Versus Fulvestrant on Urogenital Symptoms in Patients with ESR1-Mutated ER+/HER2- Metastatic Breast Cancer
January 29, 2025 10:19 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
U.S. Breast Cancer Screening and Diagnostic Market
U.S. Breast Cancer Screening & Diagnostic Market Analysis and Forecast 2024-2030 - Multi-Modality Imaging Revolutionizes Breast Cancer Diagnostics, Boosting Detection Accuracy
January 16, 2025 04:04 ET | Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "U.S. Breast Cancer Screening and Diagnostic Market: Analysis and Forecast, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Breast Cancer Brachytherapy Market
Breast Cancer Brachytherapy Market Sees $1.88 Billion Opportunity by 2035: Elekta, Varian Medical Systems, and Isoray Dominate the Competitive Landscape
January 13, 2025 06:47 ET | Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Brachytherapy Market by Technology, Product, End User, and Region" report has been added to ResearchAndMarkets.com's offering. This...